...
首页> 外文期刊>Coronary artery disease >Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization
【24h】

Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization

机译:初次经皮冠状动脉介入治疗ST段抬高型心肌梗死患者的心肌肌钙蛋白升高模式:住院期间的特征及其与心血管事件的关系

获取原文
获取原文并翻译 | 示例
           

摘要

HypothesisWe aimed to describe the kinetics and associated prognostic implications of the cardiac troponin release curve after a primary percutaneous coronary intervention (PPCI) in patients presenting with ST-segment elevation myocardial infarction (STEMI).Patients and methodsWe prospectively determined, in a prespecified timely manner, serial cardiac troponin I levels and obtained clinical, ECG, and echocardiographic data from 175 consecutive patients hospitalized with STEMI who underwent PPCI. The median peak troponin levels and time until troponin peaking were determined.ResultsThe troponin elevation curve following PPCI was single peaked, with a median value measuring 715 times the upper normal limit and a median peaking time of 8h. Later-peaking troponin levels were associated with a TIMI flow grade of 0/1 at the initiation of angiography and with lack of at least 70% regression in the ST-elevation on the first post-PPCI ECG. Higher peak values were similarly associated with these two parameters as well as with a lower blush score and with distal embolization during PPCI. Both higher peak values and later peaking of troponin were associated independently with higher occurrence of the combined adverse cardiovascular event outcomes consisting of death, congestive heart failure, and recurrent infarction.ConclusionThe cardiac troponin elevation curve following PPCI for STEMI shows a single peak and is affected by the adequacy of myocardial reperfusion. This method can serve as a simple surrogate for risk stratification of patients with STEMI who undergo PPCI.
机译:假设我们旨在描述ST段抬高型心肌梗死(STEMI)患者在初次经皮冠状动脉介入治疗(PPCI)后心脏肌钙蛋白释放曲线的动力学和相关的预后意义。 ,连续性心肌肌钙蛋白I水平,并从175例接受STEMI住院的PEMI连续患者中获得临床,心电图和超声心动图数据。结果测定了PPCI后的肌钙蛋白升高曲线是单峰,中值是正常上限的715倍,中位峰时间为8h。血管造影开始时,峰​​值肌钙蛋白水平与TIMI血流等级为0/1相关,并且在首次PPCI后ECG时,ST抬高缺乏至少70%的下降。在PPCI期间,较高的峰值与这两个参数,较低的腮红分数和远端栓塞相似。肌钙蛋白的最高峰值和后来的峰值与死亡,充血性心力衰竭和复发性梗死等合并的不良心血管事件预后的发生率较高独立相关。结论结论PEMI后STEMI的心脏肌钙蛋白升高曲线显示一个峰值并受到影响通过心肌再灌注的充分性。该方法可作为进行PPCI的STEMI患者风险分层的简单替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号